Submitted by Anonymous (not verified) on 18 June 2026 - 10:00
Opinion/decision on a Paediatric investigation plan (PIP): Stelara, ustekinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: P/0084/2021
Source: